expertise
June 20, 2011
– Comments (14)
I think I might have reached "journeyman" status in the area of biopharma stock analysis (see table 2.1 on p. 22 here). I think a little talent might help me get to "expert" status with quite a bit less than those famous 10000 h spent on the subject. I certainly hope I am not one of those that "despite high levels of motivation" "remain at the "proficiency level" of journeyman "for life". As I have mentioned before I do to some extent consider myself well qualified to "work in finance" as I am a theoretical physicist who has worked at a small brokerage company doing equity research and developing arbitrage strategies and have worked in finance & controlling for a startup company. I am certainly glad I have chosen biotechnology as a new area of expertise. I did have little choice though, as I am usually drawn to things that I consider interesting and that are considered "difficult" (which is how I ended up with "theoretical physics", I guess) and biotech fits quite nicely. I think it is now somewhat safer to listen to those "biopharma recommendations" I am giving via my "caps" game calls, blog posts and comments (especially the "fund" related ones, see here). The great investment related advantage of being a "journeyman" is the improved ability to find the real experts, which is, as checklist34 has suspected, my greatest talent. He is probably right about that ...